Sanam Moradan, Ziba Omidvar
Department of Obstetrics and Gynecology, University Hospital Amir, PO Box 351655974, Semnan, Iran.
Saudi Med J. 2011 Jan;32(1):23-6.
To compare complications of third and second generation oral contraceptive pills (OCPs).
In a randomized clinical trial from October 2007 to October 2008, 100 healthy women of reproductive age referred to Amir Hospital Family Planning Clinic and some heath centers in Semnan, Iran were randomized in 2 equal groups. They received either a third generation OCP (150 microgram desogestrel [DSG] + 30 microgram ethinylestradiol [EE]) or a second generation type (150 microgram levonorgestrel [LNG] + 30 microgram EE). Six months later, changes of weight, acne, and hirsutism severity, as well as serum titers of sex hormone-binding globulin (SHBG) and free testosterone were compared between the 2 groups.
Forty-five women were evaluated in the DSG+EE OCP group, and 46 women in the LNG+EE OCP group. The BMI was significantly higher in the second group (p=0.000) after 6 months duration. Likewise, the decrement of acne and hirsutism severity was significantly higher in the DSG+EE users (p=0.000). Mean changes of serum free testosterone (p=0.967) and SHBG (p=0.916) were comparable between the 2 groups.
In comparison with the LNG+EE OCP, the DSG+EE OCP is a contraceptive pill that significantly decreases the severity of acne and hirsutism, without any significant change in weight.
比较第三代和第二代口服避孕药(OCPs)的并发症。
在2007年10月至2008年10月进行的一项随机临床试验中,将转诊至伊朗塞姆南阿米尔医院计划生育诊所及一些健康中心的100名健康育龄妇女随机分为两组。她们分别服用第三代口服避孕药(150微克去氧孕烯[DSG]+30微克炔雌醇[EE])或第二代口服避孕药(150微克左炔诺孕酮[LNG]+30微克炔雌醇)。六个月后,比较两组之间体重、痤疮和多毛症严重程度的变化,以及性激素结合球蛋白(SHBG)和游离睾酮的血清水平。
DSG+EE口服避孕药组评估了45名妇女,LNG+EE口服避孕药组评估了46名妇女。6个月后,第二组的体重指数显著更高(p=0.000)。同样,DSG+EE使用者的痤疮和多毛症严重程度的降低也显著更高(p=0.000)。两组之间血清游离睾酮(p=0.967)和SHBG(p=0.916)的平均变化相当。
与LNG+EE口服避孕药相比,DSG+EE口服避孕药能显著降低痤疮和多毛症的严重程度,且体重无显著变化。